Literature DB >> 18768869

A RAG1 mutation found in Omenn syndrome causes coding flank hypersensitivity: a novel mechanism for antigen receptor repertoire restriction.

Serre-Yu Wong1, Catherine P Lu, David B Roth.   

Abstract

Hypomorphic RAG mutants with severely reduced V(D)J recombination activity cause Omenn Syndrome (OS), an immunodeficiency with features of immune dysregulation and a restricted TCR repertoire. Precisely how RAG mutants produce autoimmune and allergic symptoms has been unclear. Current models posit that the severe recombination defect restricts the number of lymphocyte clones, a few of which are selected upon Ag exposure. We show that murine RAG1 R972Q, corresponding to an OS mutation, renders the recombinase hypersensitive to selected coding sequences at the hairpin formation step. Other RAG1 OS mutants tested do not manifest this sequence sensitivity. These new data support a novel mechanism for OS: by selectively impairing recombination at certain coding flanks, a RAG mutant can cause primary repertoire restriction, as opposed to a more random, limited repertoire that develops secondary to severely diminished recombination activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768869      PMCID: PMC2597290          DOI: 10.4049/jimmunol.181.6.4124

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Separation-of-function mutants reveal critical roles for RAG2 in both the cleavage and joining steps of V(D)J recombination.

Authors:  J X Qiu; S B Kale; H Yarnell Schultz; D B Roth
Journal:  Mol Cell       Date:  2001-01       Impact factor: 17.970

2.  A C-terminal region of RAG1 contacts the coding DNA during V(D)J recombination.

Authors:  X Mo; T Bailin; M J Sadofsky
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  Mutational analysis of all conserved basic amino acids in RAG-1 reveals catalytic, step arrest, and joining-deficient mutants in the V(D)J recombinase.

Authors:  Leslie E Huye; Mary M Purugganan; Ming-Ming Jiang; David B Roth
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

4.  Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome).

Authors:  G de Saint-Basile; F Le Deist; J P de Villartay; N Cerf-Bensussan; O Journet; N Brousse; C Griscelli; A Fischer
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Coding sequence composition flanking either signal element alters V(D)J recombination efficiency.

Authors:  N V Boubnov; Z P Wills; D T Weaver
Journal:  Nucleic Acids Res       Date:  1995-03-25       Impact factor: 16.971

6.  RAG-1 mutations that affect the target specificity of V(D)j recombination: a possible direct role of RAG-1 in site recognition.

Authors:  M J Sadofsky; J E Hesse; D C van Gent; M Gellert
Journal:  Genes Dev       Date:  1995-09-01       Impact factor: 11.361

7.  Coding end sequence can markedly affect the initiation of V(D)J recombination.

Authors:  R M Gerstein; M R Lieber
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

8.  The cleavage efficiency of the human immunoglobulin heavy chain VH elements by the RAG complex: implications for the immune repertoire.

Authors:  Kefei Yu; Alex Taghva; Michael R Lieber
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

Review 9.  Reviewing Omenn syndrome.

Authors:  K Aleman; J G Noordzij; R de Groot; J J van Dongen; N G Hartwig
Journal:  Eur J Pediatr       Date:  2001-12       Impact factor: 3.183

Review 10.  V(D)J recombination: RAG proteins, repair factors, and regulation.

Authors:  Martin Gellert
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

View more
  6 in total

1.  Base flipping in V(D)J recombination: insights into the mechanism of hairpin formation, the 12/23 rule, and the coordination of double-strand breaks.

Authors:  Julien Bischerour; Catherine Lu; David B Roth; Ronald Chalmers
Journal:  Mol Cell Biol       Date:  2009-08-31       Impact factor: 4.272

2.  Characterization of T and B cell repertoire diversity in patients with RAG deficiency.

Authors:  Yu Nee Lee; Francesco Frugoni; Kerry Dobbs; Irit Tirosh; Likun Du; Francesca A Ververs; Heng Ru; Lisa Ott de Bruin; Mehdi Adeli; Jacob H Bleesing; David Buchbinder; Manish J Butte; Caterina Cancrini; Karin Chen; Sharon Choo; Reem A Elfeky; Andrea Finocchi; Ramsay L Fuleihan; Andrew R Gennery; Dalia H El-Ghoneimy; Lauren A Henderson; Waleed Al-Herz; Elham Hossny; Robert P Nelson; Sung-Yun Pai; Niraj C Patel; Shereen M Reda; Pere Soler-Palacin; Raz Somech; Paolo Palma; Hao Wu; Silvia Giliani; Jolan E Walter; Luigi D Notarangelo
Journal:  Sci Immunol       Date:  2016-12-16

Review 3.  Human RAG mutations: biochemistry and clinical implications.

Authors:  Luigi D Notarangelo; Min-Sung Kim; Jolan E Walter; Yu Nee Lee
Journal:  Nat Rev Immunol       Date:  2016-03-21       Impact factor: 53.106

Review 4.  RAG Deficiency: Two Genes, Many Diseases.

Authors:  Ottavia M Delmonte; Catharina Schuetz; Luigi D Notarangelo
Journal:  J Clin Immunol       Date:  2018-07-25       Impact factor: 8.317

5.  Hypomorphic Rag1 mutations alter the preimmune repertoire at early stages of lymphoid development.

Authors:  L M Ott de Bruin; M Bosticardo; A Barbieri; S G Lin; J H Rowe; P L Poliani; K Ching; D Eriksson; N Landegren; O Kämpe; J P Manis; L D Notarangelo
Journal:  Blood       Date:  2018-05-09       Impact factor: 22.113

6.  A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.

Authors:  Yu Nee Lee; Francesco Frugoni; Kerry Dobbs; Jolan E Walter; Silvia Giliani; Andrew R Gennery; Waleed Al-Herz; Elie Haddad; Francoise LeDeist; Jack H Bleesing; Lauren A Henderson; Sung-Yun Pai; Robert P Nelson; Dalia H El-Ghoneimy; Reem A El-Feky; Shereen M Reda; Elham Hossny; Pere Soler-Palacin; Ramsay L Fuleihan; Niraj C Patel; Michel J Massaad; Raif S Geha; Jennifer M Puck; Paolo Palma; Caterina Cancrini; Karin Chen; Mauno Vihinen; Frederick W Alt; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2013-11-28       Impact factor: 10.793

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.